Monitoring the Effectiveness of Treatment in Women with Schizophrenia: New Specialized Cooperative Approaches

M Natividad, MV Seeman, JP Paolini, A Balagué… - Brain Sciences, 2023 - mdpi.com
Women with schizophrenia have specific health needs that differ from those of men and that
change through successive life stages. We aimed to review the biopsychosocial literature on …

Challenges, unmet needs and future directions–a critical evaluation of the clinical trial landscape in schizophrenia research

E Wagner, JJ Luykx, W Strube… - Expert Review of Clinical …, 2024 - Taylor & Francis
Introduction Developing novel antipsychotic mechanisms of action and repurposing
established compounds for the treatment of schizophrenia is of utmost importance to …

Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts

A Gillespie, EM Walker, E Hannon, G McQueen… - medRxiv, 2023 - medrxiv.org
The second-generation antipsychotic clozapine is used as a medication for treatment-
resistant schizophrenia. It has previously been associated with epigenetic changes in pre …

[HTML][HTML] Biomarkers of treatment-resistant schizophrenia: A systematic review

C Pisanu, G Severino, A Minelli, M Dierssen… - Neuroscience …, 2024 - Elsevier
Abstract Treatment-resistant schizophrenia (TRS) is associated with great disability,
functional impairment, and substantial socioeconomic costs. While clozapine is indicated in …

[PDF][PDF] 难治性精神分裂症药物治疗进展

陆铖, 马瑞, 高华, 贾乐川 - 临床药物治疗杂志, 2023 - lcywzlzz.com
精神分裂症是临床常见的精神疾病之一, 以思维, 行为, 情感障碍, 精神活动不协调为主要临床
表现, 具有病情迁延, 复发率高, 预后差等特点, 临床多采用药物治疗, 控制患者病情 …

[引用][C] Cerebral blood flow in treatment resistant schizophrenia and during clozapine treatment

J Sun, F Zelaya, KV Sendt, G Mcqueen, A Gillespie… - Neuroscience …, 2024 - Elsevier